[NDRA] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[NDRA] ENDRA Life Sciences Inc.
Announcement Date
26-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -40.86%
YoY- -103.25%
Quarter Report
NDRA's Result
NDRA's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 0 0 0 0 7 516 -
PBT -3,290 -3,105 -2,251 -4,809 -2,366 -2,295 -687 29.81%
Tax -24 121 4 1,575 0 0 370 -
NP -3,266 -3,105 -2,251 -4,809 -2,366 -2,295 -687 29.65%
Tax Rate - - - - - - - -
Total Cost 3,266 3,105 2,251 4,809 2,366 2,301 1,202 18.11%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -33,498.39 -133.22 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -1.03 -1.48 -1.88 -8.36 -6.37 -11.75 -3.52 -18.51%
EPS Diluted -1.03 -1.48 -1.88 -8.36 -6.37 -11.75 -3.52 -18.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.